USA flag logo/image

An Official Website of the United States Government

Platform for myocardial infarct MRI and delivery of therapeutics

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / STTR
Agency Tracking Number:
R41HL116014
Solicitation Year:
2012
Solicitation Topic Code:
NHLBI
Solicitation Number:
PA11-097
Small Business Information
CELSENSE, INC.
603 STANWIX STREET SUITE 348 PITTSBURGH, PA 15222-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Platform for myocardial infarct MRI and delivery of therapeutics
Agency: HHS
Contract: 1R41HL116014-01
Award Amount: $379,160.00
 

Abstract:

Myocardial infarction (MI) afflicts more than one million persons per year in the United States alone. MI results in permanent left ventricle (LV) scarring that causes diminished pump efficiency and, commonly, heart failure. Towards reduction or elimination of scarring, there is increasing interest in reparative biological materials, such as cells and proteins, that are introduced into the affected region of the LV early after MI. We believe that such an approach will eventually become part of a standard ofcare. The most promising route for the delivery of such materials is direct LV injection (DLVI). Thus far, the utility of DLVI has been hampered by the lack methods for accurate spatial targeting of affected tissue. This has greatly impeded clinical translation of promising materials. The goal of this project is to devise cutting edge imaging tools to visualize infarcted regions using MRI.

Principal Investigator:

Eric T. Ahrens
412-268-5105
eta@celsense.com

Business Contact:

Amy Wesa
412-263-2870
awesa@celsense.com
Small Business Information at Submission:

CELSENSE, INC.
603 STANWIX STREET SUITE 348 PITTSBURGH, PA 15222-

EIN/Tax ID: 120298487
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
CELSENSE, INC.
603 STANWIX STREET
SUITE 348
PITTSBURGH, PA 15222-
Contact: